← brief for 2026-10-21 · Slowing decline

Real-world safety profile of finerenone in patients with type 2 diabetes and chronic kidney disease: a multi-database pharmacovigilance analysis of the FAERS and JADER systems

Article C Peer reviewed Observational

Key takeaways

This review checked safety reports for a drug called finerenone. It looked at data from the U.S. and Japan to see if the drug causes side effects in real life. The study shows a link between the drug and certain reports, but it does not prove the drug causes them.

Who did this work

Dan Zhang (Nantong University) · Yun Zhao (Nantong University) · Haiting Chen (Nantong University) · Yang Miao (Nantong University)

Source

Article · OpenAlex, CKD works · 2026-10-20
https://doi.org/10.3389/fcdhc.2026.1984666